FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310209074> ?p ?o ?g. }

• W4310209074 endingPage "3770" @default.
• W4310209074 startingPage "3763" @default.
• W4310209074 abstract "The study aimed to investigate the anticancer effect of E-prostanoid receptor 1 (EP1) antagonist, SC19220, alone or in combination with the COX-2 inhibitor Celecoxob(CXB)® in mice bearing solid Ehrlich carcinoma (SEC).The tumors were induced in 40 female mice, which were divided randomly into four equal groups (n= 10 in each group): Tumor control, CXB, EP1 antagonist, and co-treatment. CXB (10mg/kg) and EP1 antagonist (2mg/kg) were given intraperitoneally every three days, six times in total, then tissue was extracted and prepared for histopathology and measurement of weight, PGE2, and gene expression of EP1 and β 1 integrin.Both inhibitors, alone or in combination, showed a significant (p<0.001) antitumorigenic effect by decreasing, significantly (p<0.001), each of the tumor weights, tumor volumes, PGE2 levels, EP1 and β1-integrin gene expression along with increasing, significantly (p<0.001), the P53 tumor suppressor protein. The survival rate was improved from 80% in the control group to reach 100% in the treated groups. The co-treatment by CXB and EP1 antagonist showed a marked decrease in tumor weights and volumes as compared with the single treatment. In parallel, the histopathological findings showed enhanced apoptosis and diminished necrosis in the co-treated group.EP1 antagonist proved an antitumorigenic effect alone or combined with CXB and could play a new therapeutic strategy against breast cancer." @default.
• W4310209074 created "2022-11-30" @default.
• W4310209074 creator A5001218220 @default.
• W4310209074 creator A5007382115 @default.
• W4310209074 creator A5050102756 @default.
• W4310209074 creator A5079045771 @default.
• W4310209074 creator A5079629865 @default.
• W4310209074 date "2022-11-01" @default.
• W4310209074 modified "2023-10-17" @default.
• W4310209074 title "Blocking of The Prostaglandin E2 Receptor as a Therapeutic Strategy for Treatment of Breast Cancer: Promising Findings in a Mouse Model" @default.
• W4310209074 cites W1483007439 @default.
• W4310209074 cites W1981017032 @default.
• W4310209074 cites W1995068068 @default.
• W4310209074 cites W1998576925 @default.
• W4310209074 cites W2023791568 @default.
• W4310209074 cites W2034979568 @default.
• W4310209074 cites W2056142361 @default.
• W4310209074 cites W2095484924 @default.
• W4310209074 cites W2107277218 @default.
• W4310209074 cites W2135794748 @default.
• W4310209074 cites W2159044625 @default.
• W4310209074 cites W2168462515 @default.
• W4310209074 cites W2192080449 @default.
• W4310209074 cites W2331657373 @default.
• W4310209074 cites W2415659851 @default.
• W4310209074 cites W2419620437 @default.
• W4310209074 cites W2515224540 @default.
• W4310209074 cites W2522214018 @default.
• W4310209074 cites W2569631385 @default.
• W4310209074 cites W2611117534 @default.
• W4310209074 cites W2766276773 @default.
• W4310209074 cites W2772715662 @default.
• W4310209074 cites W2789604475 @default.
• W4310209074 cites W2893949635 @default.
• W4310209074 cites W2898453202 @default.
• W4310209074 cites W2966811667 @default.
• W4310209074 cites W3090745705 @default.
• W4310209074 cites W3111629147 @default.
• W4310209074 cites W3128646645 @default.
• W4310209074 cites W3186655683 @default.
• W4310209074 doi "https://doi.org/10.31557/apjcp.2022.23.11.3763" @default.
• W4310209074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36444589" @default.
• W4310209074 hasPublicationYear "2022" @default.
• W4310209074 type Work @default.
• W4310209074 citedByCount "2" @default.
• W4310209074 countsByYear W43102090742023 @default.
• W4310209074 crossrefType "journal-article" @default.
• W4310209074 hasAuthorship W4310209074A5001218220 @default.
• W4310209074 hasAuthorship W4310209074A5007382115 @default.
• W4310209074 hasAuthorship W4310209074A5050102756 @default.
• W4310209074 hasAuthorship W4310209074A5079045771 @default.
• W4310209074 hasAuthorship W4310209074A5079629865 @default.
• W4310209074 hasBestOaLocation W43102090741 @default.
• W4310209074 hasConcept C121608353 @default.
• W4310209074 hasConcept C126322002 @default.
• W4310209074 hasConcept C134018914 @default.
• W4310209074 hasConcept C170493617 @default.
• W4310209074 hasConcept C17991360 @default.
• W4310209074 hasConcept C190283241 @default.
• W4310209074 hasConcept C2776885963 @default.
• W4310209074 hasConcept C2778122271 @default.
• W4310209074 hasConcept C2780664492 @default.
• W4310209074 hasConcept C502942594 @default.
• W4310209074 hasConcept C503630168 @default.
• W4310209074 hasConcept C530470458 @default.
• W4310209074 hasConcept C55493867 @default.
• W4310209074 hasConcept C71924100 @default.
• W4310209074 hasConcept C86803240 @default.
• W4310209074 hasConcept C98274493 @default.
• W4310209074 hasConceptScore W4310209074C121608353 @default.
• W4310209074 hasConceptScore W4310209074C126322002 @default.
• W4310209074 hasConceptScore W4310209074C134018914 @default.
• W4310209074 hasConceptScore W4310209074C170493617 @default.
• W4310209074 hasConceptScore W4310209074C17991360 @default.
• W4310209074 hasConceptScore W4310209074C190283241 @default.
• W4310209074 hasConceptScore W4310209074C2776885963 @default.
• W4310209074 hasConceptScore W4310209074C2778122271 @default.
• W4310209074 hasConceptScore W4310209074C2780664492 @default.
• W4310209074 hasConceptScore W4310209074C502942594 @default.
• W4310209074 hasConceptScore W4310209074C503630168 @default.
• W4310209074 hasConceptScore W4310209074C530470458 @default.
• W4310209074 hasConceptScore W4310209074C55493867 @default.
• W4310209074 hasConceptScore W4310209074C71924100 @default.
• W4310209074 hasConceptScore W4310209074C86803240 @default.
• W4310209074 hasConceptScore W4310209074C98274493 @default.
• W4310209074 hasIssue "11" @default.
• W4310209074 hasLocation W43102090741 @default.
• W4310209074 hasLocation W43102090742 @default.
• W4310209074 hasLocation W43102090743 @default.
• W4310209074 hasOpenAccess W4310209074 @default.
• W4310209074 hasPrimaryLocation W43102090741 @default.
• W4310209074 hasRelatedWork W1976219263 @default.
• W4310209074 hasRelatedWork W1991266606 @default.
• W4310209074 hasRelatedWork W1992689150 @default.
• W4310209074 hasRelatedWork W2058127676 @default.
• W4310209074 hasRelatedWork W2083576828 @default.
• W4310209074 hasRelatedWork W2108664779 @default.
• W4310209074 hasRelatedWork W2110143838 @default.

• next